Posts Tagged ‘Michael Blane’
Sichenzia Ross Ference LLP Represents Murphy Canyon Acquisition Corp. in Definitive Merger Agreement with Conduit Pharmaceuticals Limited
Press Release – New York, NY November 9, 2022 – Sichenzia Ross Ference LLP announced today that it represented Murphy Canyon Acquisition Corp. (Nasdaq: MURF), a publicly traded special purpose acquisition company (SPAC) in a definitive merger agreement with Conduit Pharmaceuticals Limited (“Conduit”). The combined company is anticipated to have an implied initial enterprise value…
Read MoreSichenzia Ross Ference LLP Represents Splash Beverage Group, Inc. in $3.1 Million Underwritten Public Offering
Press Release – New York, NY – September 28, 2022 – Sichenzia Ross Ference LLP today announced that it represented Splash Beverage Group, Inc. (NYSE American: SBEV), a portfolio company of leading beverage brands, in an underwritten public offering. The offering consisted of 2,000,000 shares of common stock at a price to the public of $1.55 per…
Read MoreSichenzia Ross Ference LLP Represents Roth Capital Partners in Public Offering of Common Stock of Crown Electrokinetics Corp.
Sichenzia Ross Ference LLP Represents Spartan Capital Securities LLC and Pacific Century Securities LLC in $14.1 Million Initial Public Offering of Common Shares of Lytus Technologies Holdings PTV. Ltd.
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $19.5 Million Private Placement Offering
Sichenzia Ross Ference LLP Represents Sharps Technology, Inc. in $16 Million Initial Public Offering
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $8 Million Private Placement
Sichenzia Ross Ference LLP Represents Murphy Canyon Acquisitions Corp. in $132.25 Million Initial Public Offering and NASDAQ Listing
Sichenzia Ross Ference LLP Represents Parsec Capital Acquisition Corp. in $86.3 Million Initial Public Offering
